148 related articles for article (PubMed ID: 30862130)
1. Synthesis of New Indanyl Nucleoside Analogues and their Biological Evaluation on Hepatitis C Virus (HCV) Replicon.
Gómez ME; Gentile EA; Martini MF; Cuestas ML; Mathet VL; Moltrasio GY; Moglioni AG
Molecules; 2019 Mar; 24(5):. PubMed ID: 30862130
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of 2'-substituted nucleosides on hepatitis C virus replication correlates with metabolic properties in replicon cells.
Tomassini JE; Getty K; Stahlhut MW; Shim S; Bhat B; Eldrup AB; Prakash TP; Carroll SS; Flores O; MacCoss M; McMasters DR; Migliaccio G; Olsen DB
Antimicrob Agents Chemother; 2005 May; 49(5):2050-8. PubMed ID: 15855531
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of bimorpholine and its carbanucleoside.
Ausmees K; Selyutina A; Kütt K; Lippur K; Pehk T; Lopp M; Zusinaite E; Merits A; Kanger T
Nucleosides Nucleotides Nucleic Acids; 2011 Nov; 30(11):897-907. PubMed ID: 22060554
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-HCV evaluation of 4'(alpha)-ethyl and 2'(beta)-methyl-carbodine analogues.
Li H; Yoo JC; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2009 Sep; 28(9):809-20. PubMed ID: 20183620
[TBL] [Abstract][Full Text] [Related]
5. The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine.
Smith DB; Kalayanov G; Sund C; Winqvist A; Pinho P; Maltseva T; Morisson V; Leveque V; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M
J Med Chem; 2009 Jan; 52(1):219-23. PubMed ID: 19055482
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of novel carbocyclic versions of 2'-spirocyclopropyl ribonucleosides as potent anti-HCV agents.
Oh CH; Kim E; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2011 Jun; 30(6):423-39. PubMed ID: 21780908
[TBL] [Abstract][Full Text] [Related]
7. Arylethynyltriazole acyclonucleosides inhibit hepatitis C virus replication.
Zhu R; Wang M; Xia Y; Qu F; Neyts J; Peng L
Bioorg Med Chem Lett; 2008 Jun; 18(11):3321-7. PubMed ID: 18445526
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of novel HCV replication inhibitors.
McGowan DC; Khamlichi MD; De Groot A; Pauwels F; Delouvroy F; Van Emelen K; Simmen K; Raboisson P
Mol Divers; 2017 May; 21(2):475-481. PubMed ID: 28293834
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro activity evaluation of 2',3'-C-dimethyl carbocyclic nucleoside analogues as potential anti-HCV agents.
Ko OH; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2009 Aug; 28(8):761-71. PubMed ID: 20183615
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 5-haloethynyl- and 5-(1,2-dihalo)vinyluracil nucleosides: antiviral activity and cellular toxicity.
Escuret V; Aucagne V; Joubert N; Durantel D; Rapp KL; Schinazi RF; Zoulim F; Agrofoglio LA
Bioorg Med Chem; 2005 Nov; 13(21):6015-24. PubMed ID: 16023859
[TBL] [Abstract][Full Text] [Related]
11. In silico identification, design and synthesis of novel piperazine-based antiviral agents targeting the hepatitis C virus helicase.
Bassetto M; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; Courtney-Smith M; Brancale A
Eur J Med Chem; 2017 Jan; 125():1115-1131. PubMed ID: 27810598
[TBL] [Abstract][Full Text] [Related]
12. Anti-hepatitis C virus activity of novel beta-d-2'-C-methyl-4'-azido pyrimidine nucleoside phosphoramidate prodrugs.
Rondla R; Coats SJ; McBrayer TR; Grier J; Johns M; Tharnish PM; Whitaker T; Zhou L; Schinazi RF
Antivir Chem Chemother; 2009 Oct; 20(2):99-106. PubMed ID: 19843980
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus in vitro replication is efficiently inhibited by acridone Fac4.
Campos GRF; Bittar C; Jardim ACG; Shimizu JF; Batista MN; Paganini ER; Assis LR; Bartlett C; Harris M; Bolzani VDS; Regasini LO; Rahal P
J Gen Virol; 2017 Jul; 98(7):1693-1701. PubMed ID: 28699869
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methyl purine nucleosides as inhibitors of hepatitis C virus RNA replication.
Clark JL; Mason JC; Hollecker L; Stuyver LJ; Tharnish PM; McBrayer TR; Otto MJ; Furman PA; Schinazi RF; Watanabe KA
Bioorg Med Chem Lett; 2006 Mar; 16(6):1712-5. PubMed ID: 16368235
[TBL] [Abstract][Full Text] [Related]
15. Replicon cell culture system as a valuable tool in antiviral drug discovery against hepatitis C virus.
Horscroft N; Lai VC; Cheney W; Yao N; Wu JZ; Hong Z; Zhong W
Antivir Chem Chemother; 2005; 16(1):1-12. PubMed ID: 15739617
[TBL] [Abstract][Full Text] [Related]
16. A conformational mimetic approach for the synthesis of carbocyclic nucleosides as anti-HCV leads.
Kasula M; Balaraju T; Toyama M; Thiyagarajan A; Bal C; Baba M; Sharon A
ChemMedChem; 2013 Oct; 8(10):1673-80. PubMed ID: 23943612
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-hepatitis C virus activity of 2'(beta)-hydroxyethyl and 4'(alpha)-hydroxymethyl carbodine analogues.
Liu LJ; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2009 Nov; 28(11):1007-15. PubMed ID: 20183569
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 1,2,3-triazolo-carbanucleoside analogues of ribavirin targeting an HCV in replicon.
Saito Y; Escuret V; Durantel D; Zoulim F; Schinazi RF; Agrofoglio LA
Bioorg Med Chem; 2003 Aug; 11(17):3633-9. PubMed ID: 12901908
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of α-aryl-α-tetralone derivatives as hepatitis C virus inhibitors.
Manvar D; Fernandes Tde A; Domingos JL; Baljinnyam E; Basu A; Junior EF; Costa PR; Kaushik-Basu N
Eur J Med Chem; 2015 Mar; 93():51-4. PubMed ID: 25644675
[TBL] [Abstract][Full Text] [Related]
20. Cinnamic acid derivatives inhibit hepatitis C virus replication via the induction of oxidative stress.
Amano R; Yamashita A; Kasai H; Hori T; Miyasato S; Saito S; Yokoe H; Takahashi K; Tanaka T; Otoguro T; Maekawa S; Enomoto N; Tsubuki M; Moriishi K
Antiviral Res; 2017 Sep; 145():123-130. PubMed ID: 28780423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
